| GraphWear presented SweatSmart beta at the NASDAQ|
GraphWear presented SweatSmart beta at the NASDAQ bell closing ceremony along with the CEO of the 49ers, Jed York and were featured on Times Square.
This is the first time in human history that players would be able to extract their health information in real-time without blood pricks and they are excited to work with their customers to that end!
| Check out GraphWear's feature video.|
| Lunch Seminar: June 7, 12:30 - 1:30 PM|
Amgen Innovator Series:
Enabling global analysis of protein expression by next generation sequencing
Luciano Brocchieri, PhD
TB-SEQ, Inc., promotes implementations and development of the RIBO-seq platform technology, by which protein expression can be monitored and discovered with high coverage and resolution by deep-sequencing the 'translatome', i.e., the genome-wide pool of translated mRNAs. Selective translational control of gene expression is emerging as a widespread mechanism for the regulation of functional activities of biological systems. RIBO-seq has enabled discovery of key regulatory components and mechanisms of post-transcriptional control of translation, uncovering new functionalities and targets for intervention.
| Luciano Brocchieri, PhD, Co-Founder of TB-SEQ, was formerly a Senior Scientist at Stanford University, Dept. of Mathematics, and a faculty member at the University of Florida, Department of Molecular Genetics and Microbiology. Luciano has a background in theoretical population genetics, bioinformatics, and molecular evolution. He is the author of extensive work on properties and evolution of protein families and nucleic acid sequences and has developed new methods for gene identification and for the analysis of sequencing data. Luciano is also Editor-in-Chief of the Journal of Phylogenetics and Evolutionary Biology. Along with TB-SEQ Co-founder Silvia Tornaletti, a Stanford-educated biochemist and former faculty member at the University of Florida, have previously collaborated on the analysis of translation in the bacterial pathogen Pseudomonas aeruginosa and in aging muscle.|
| Lunch Seminar: June 20, 12:30 - 1:30 PM|
Tips and Tricks to Help Develop and Run Microplate-based Assays
Mark Rothenberg, PhD
Scientific Training and Education, Corning
Today's scientists rely on both biochemical and cell-based in vitro assays for their research. Critical parameters for achieving success with these assays include understanding the assay dynamics, the instrumentation involved in reading the assay, and, in the case of cell-based assays, understanding how the environment in which the cells are grown impacts cellular physiology. Factors such as microplate geometry, density, surfaces, and instrumentation all play important roles in the success of the assay. In this seminar, we will discuss ways to enhance your assay performance. Topics to be discussed include:
- Microplate selection and its role in the success of the assay
- Important considerations for liquid handling
- The importance of tips to your overall assay
- Choosing the correct tip for your liquid handling needs
- The importance of choosing the correct instrumentation and settings to run your assay
| Mark Rothenberg graduated from Emory University with his PhD in Cell and Developmental Biology. Over the past 25 years Mark has held positions in both academia and industry where he has developed an expertise in the areas of assay development, cell culture (multiple types including primary lines), and cell culture scale-up. Prior to his current position as Manager Scientific Training and Education he worked and led the applications team.|
| Seminar: June 21, 11:00 - 12:00 PM, Lunch to Follow|
Demystifying Corporate Venture - an introduction to Novartis Venture Fund and our participation in the biotech ecosystem
Venture Partner, Novartis Venture Fund
| Giovanni Ferrara is a Venture Partner in Cambridge, MA, USA. He joined NVF from portfolio company Sorbent Therapeutics, where he was consulting Chief Business Officer and a consultant to leading west coast venture capital firms. Most recently, Giovanni was consulting Chief Business Officer to Sorbent Therapeutics. Previously, he was Managing Director and General Partner at Burrill & Company and began his venture capital career at GeneChem Management, where in addition to his investing responsibilities, he held operating positions in portfolio companies, including CEO of Targanta Therapeutics. He began his career in healthcare at a cancer treatment center researching experimental therapies. He received his MBA and MSc from McGill University. Giovanni serves on the boards of, E-scape, NeuroVia and Thesan Pharmaceuticals.|
| Lunch and Learn: June 28, 11:30 - 1:00 PM|
Juggle the Struggle: Keep up with today's hottest HR trends & overcome top compliance concerns
Director of Human Resource Expertise, TriNet
Join us for complimentary lunch as we walk you through some of the most pressing HR concerns today. Covering regulations that are constantly top-of-mind and in the news, this presentation takes you through the updated regulations, why they matter for your business, and TriNet's suggestions on how to tackle compliance issues in 2017.
| Jacqueline Breslin is TriNet's Director of the Human Resources Center of Expertise. She has 20 years' experience in Human Resources. Jackie leads a team dedicated to compliance, workplace investigations, and guidance for challenging employee-relations issues. She has experience implementing and managing HR programs to include policy development, performance management, compensation, recruitment and retention, learning and development, and coaching. Jackie earned the Stevie award for Human Resources Professional of the Year in 2016.|
| Training: June 29, 10:00 - 12:00 PM|
MACSQuant® Flow Cytometer Intro and Training Session
Flow Cytometer Applications Specialist, Miltenyi
| Join the Flow Revolution with MACSQuant!|
Powerful and compact
Automated instrument calibration and compensation
- Carry out multi-parametric flow cytometry via three lasers and up to ten optical channels
- Perform sophisticated phenotypic analysis and functional studies, e.g., cell cycle, apoptosis, and cell proliferation analysis on a variety of cell types, such as whole blood, cell lines, and yeast
- Perfectly suited for fluorochrome-conjugated MACS® Antibodies
Miltenyi would like to invite users for one-on-one training sessions in the afternoon from 1:00 - 5:00 PM. Please contact Christine Crosby to schedule.
- Automated optimization of channel voltage settings to ensure consistently high performance.
- Single-stained cells or compensation beads can be used for fully automated compensation of up to eight colors via an 8×8 matrix.